Rexall Sundown, Inc. v. Perrigo Co.Rexall Sundown, Inc. v. Perrigo Co.
MEMORANDUM AND ORDER
Plaintiff Rexall Sundown, Inc. (“Rexall” or “plaintiff’) brought this false advertising action against Perrigo Company (“Perrigo” or “defendant”), claiming violations of Section 43(a) of the Lanham Act,
Both parties sell glucosamine chondroitin nutritional supplements, and each claimed that the other had made false and misleading promotional statements on the packaging of the supplements that it sold. The case was tried before a jury between March 15 and April 7, 2010.
On its claim against Perrigo, Rexall sought to recover Perrigo’s profits, as permitted under Section 35(a) of the Lanham Act,
I. Background
Plaintiff Rexall sells a number of nutritional supplements under the brand name Osteo Bi-Flex. The Osteo Bi-Flex products are intended to promote joint health. Defendant Perrigo sells competing store-brand (or “generic”) joint-care supplements (hereinafter “the Perrigo products”).
Rexall’s claim against Perrigo was based on Perrigo’s use of statements such as “Compare to Osteo Bi-Flex Glucosamine Chondroitin MSM with Joint Shield Ingredients,” “Compare to Osteo Bi-Flex Ingredients,” “Compare to Ingredients of Osteo Bi-Flex,” or “Compare Osteo Bi-Flex,” on the packaging of the Perrigo products (hereinafter the “Compare To statements.”). Rexall claimed that the Compare To statements implied that the Perrigo products either contain the same ingredients as Osteo Bi-Flex or have the same effectiveness as Osteo Bi-Flex. Rexall argued that neither of these implied messages was accurate and that, therefore, the Compare To statements constituted false advertising in violation of Section 43(a) of the Lanham Act, 15 U.S.C. 1125(a).
As monetary relief for Perrigo’s alleged Lanham Act violation, Rexall sought Perrigo’s profits from the sale of the products. Section 35(a) of the Lanham Act,
II. Discussion
Perrigo argued that, under
Both the plain text of the statute and case law support the proposition that, when a plaintiff seeks a defendant’s profits in a Lanham Act false advertising case, the plaintiff must establish only the defendant’s sales of the product at issue; the defendant bears the burden of showing all costs and deductions, including any portion of sales that was not due to the allegedly false advertising.
The Court’s analysis begins with the plain text of the statute at issue, Section 35(a) of the Lanham Act,
Case law applying
Perrigo argued that many of these cases are not applicable here because they involve trademark infringement, not false advertising. This argument is without merit. As alluded to above,
The Second Circuit false advertising ease that Perrigo did rely on,
Burndy Corp. v. Teledyne Industries, Inc.,
Bumdy
is distinguishable from the instant case. The plaintiff in
Bumdy
could not obtain an accounting of profits because it could not demonstrate an injury caused by defendant’s actions. In short,
Bumdy
is a case about causation. Here, by contrast, causation was presumed because the Compare To statements on the Perrigo products explicitly referenced Osteo Bi-Flex.
See McNeilab, Inc. v. Am. Home Prods. Corp.,
Finally, although the Court holds that the defendant bears the burden of apportionment, any profit award under the Lanham Act is subject to the principles of equity, and the statute also requires that any monetary award serve as “compensation and not a penalty.”
See
III. Conclusion
In sum, the Court finds that, in a Lanham Act false advertising case, where the plaintiff proves all elements on the issue of liability (including causation) and establishes that it is entitled to disgorgement of the defendant’s profits, the plaintiff bears the burden of showing only the sales of the violative products. The defendant must establish any deductions, including costs and any apportionment for sales that were not due to the allegedly false or misleading statements.
SO ORDERED.
Notes
.
When a violation of any right of the registrant of a mark registered in the Patent and Trademark Office, a violation under
There is some debate about whether willfulness remains a pre-requisite for obtaining a defendant's profits.
See, e.g., Koon Chun Hing Kee Soy & Sauce Factory, Ltd. v. Star Mark Mgmt., Inc.,
No. 04-CV-2293 (JFB)(SMG),
. Commentary on the Lanham Act is also consistent with these cases. See, e.g., J. Thomas McCarthy, 5 McCarthy on Trademarks and Unfair Competition § 30:65 (4th ed.) ("Under the federal Lanham Act, as well as the common law, it is the infringer's burden to prove any proportion of his total profits which may not have been due to use of the infringing mark.”); id. § 30.66 ("Thus, the plaintiff need only prove gross sales and it is then the infringer's burden to prove (1) which, if any, of those sales were not attributable to the wrongful act, and (2) deductible costs and expenses to arrive at net profits.” (emphasis added)); David S. Almeling, The Infringement-Plus-Equity Model: A Better Way to Award Monetary Relief in Trademark Cases, 14 J. Intel! Prop. L. 205, 224-25 (2007) ("Specifically, the Lanham Act provides that '[i]n assessing profits the plaintiff shall be required to prove defendant’s sales only; defendant must prove all elements of cost or deduction claimed.’ In other words, if the defendant can apportion its profits, then the plaintiff is given the appropriate amount and not a windfall. If the defendant cannot apportion its profits, equity supports the view that, having already been held liable for infringement, it is the defendant who should suffer the consequences of its own failure to apportion its profits.”)
. Many courts, however, despite the “express limitation” in the statute’s text, applied the statute to infringement of unregistered trademarks, false advertising, and other Lanham Act causes of action.
See Burndy Corp. v. Teledyne Indus. Inc.,